2024
Regional anesthesia for transplantation surgery ‐ A White Paper Part 2: Abdominal transplantation surgery
Ander M, Mugve N, Crouch C, Kassel C, Fukazawa K, Isaak R, Deshpande R, McLendon C, Huang J. Regional anesthesia for transplantation surgery ‐ A White Paper Part 2: Abdominal transplantation surgery. Clinical Transplantation 2024, 38: e15227. PMID: 38289879, DOI: 10.1111/ctr.15227.Peer-Reviewed Original ResearchConceptsSociety for the Advancement of Transplant AnesthesiaTransplant surgeryRegional anesthesiaPostoperative pain controlRegional anesthetic techniquesDevelopment of enhanced recoveryAvailability of ultrasound machinesAbdominal transplantationOpioid usePain controlAnalgesic effectNeuraxial blockPerioperative culturesPatient's hemodynamicsSurgeryUterus transplantationAnesthetic techniqueTransplantationReview available literatureAdvancement of Transplant AnesthesiaSystemic reviewTransplantation techniquesAnesthesiaLiterature searchUltrasound machine
2023
Regional anesthesia for transplantation surgery – A white paper part 1: Thoracic transplantation surgery
Ander M, Mugve N, Crouch C, Kassel C, Fukazawa K, Izaak R, Deshpande R, McLendon C, Huang J. Regional anesthesia for transplantation surgery – A white paper part 1: Thoracic transplantation surgery. Clinical Transplantation 2023, 37: e15043. PMID: 37306898, PMCID: PMC10834230, DOI: 10.1111/ctr.15043.Peer-Reviewed Original ResearchConceptsTransplantation surgeryRegional anesthesiaOpioid usePostoperative pain controlRegional anesthetic techniquesAnalgesic modalitiesAnalgesic effectivenessPain controlSurgery protocolNeuraxial blockPatient's hemodynamicsAnesthetic techniqueAbdominal transplantationTransplant anesthesiaSurgeryAnesthesiaSystemic reviewEnhanced recoveryTransplant techniquesPerioperative culturesLiterature searchFormal guidelinesAvailable literatureUltrasound machineTask Force
2022
COVID-19: National Pandemic Management Strategies and their Efficacies and Impacts on the Number of Secondary Cases and Prognosis: A Systematic Review
Hatami H, Qaderi S, Shah J, Rezaeian A, Farsi Y, Alinasab F, Qaderi F, Khosravi A, Bazgir N, Shah A. COVID-19: National Pandemic Management Strategies and their Efficacies and Impacts on the Number of Secondary Cases and Prognosis: A Systematic Review. International Journal Of Preventive Medicine 2022, 13: 100. PMID: 36119952, PMCID: PMC9470909, DOI: 10.4103/ijpvm.ijpvm_464_20.Peer-Reviewed Original ResearchSystematic reviewHealth care administratorsPreferred Reporting ItemsPublic health officialsCare administratorsReporting ItemsPandemic management strategiesCohort studyInclusion criteriaDatabases PubMedHealth officialsCOVID-19Google ScholarCase detectionPeer reviewPersonal hygieneSystemic reviewPublished articlesRespiratory diseaseCOVID-19 outbreak
2021
Efficacy and safety of epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) monotherapy for advanced EGFR-mutated non-small cell lung cancer: systematic review and meta-analysis.
Lee H, Jeong G, Li H, Kim M, Kim J, Park S, Han Y, Lee K, Kronbichler A, Hong S, Ghayda R, Luchini C, Nottegar A, Koyanagi A, Smith L, Jacob L, Dragioti E, Radua J, Cargnin S, Terrazzino S, Thompson T, Yon D, Lee S, Yang J, Wasuwanich P, Shin J, Gamerith G. Efficacy and safety of epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) monotherapy for advanced EGFR-mutated non-small cell lung cancer: systematic review and meta-analysis. European Review For Medical And Pharmacological Sciences 2021, 25: 6232-6244. PMID: 34730203, DOI: 10.26355/eurrev_202110_26993.Peer-Reviewed Original ResearchConceptsEpidermal growth factor receptor tyrosine kinase inhibitorsEGFR-mutant non-small cell lung cancerNon-small cell lung cancerProgression-free survivalSevere adverse eventsAdvanced EGFR-mutated non-small cell lung cancerSafety of epidermal growth factor receptor tyrosine kinase inhibitorsEpidermal growth factor receptor tyrosine kinase inhibitor therapyGrowth factor receptor tyrosine kinase inhibitorsReceptor tyrosine kinase inhibitorsStandard chemotherapyCell lung cancerOverall survivalAdverse eventsLung cancerKinase inhibitorsCompared to standard chemotherapyHazard ratioReducing severe adverse eventsAnalysis of adverse eventsIndirect meta-analysesChemotherapyCochrane LibraryInclusion criteriaSystemic review
2020
Peer Supports in Recovery
Schmutte T, Guy K, Davidson L, Bellamy C. Peer Supports in Recovery. 2020, 245-252. DOI: 10.1007/978-3-030-19847-3_21.Peer-Reviewed Original ResearchSerious mental illnessMental illnessCostly acute care servicesPeer supportPublic mental health settingsAcute care servicesCurrent evidence baseMental health settingsMental health systemPhysical health outcomesRecovery-oriented practiceEvidence-based practiceSystemic reviewHealth outcomesHealth settingsCare servicesHealth systemPeer supportersEvidence baseMental healthSubstance useIllnessPromising additionInvolvement of peopleCare
2012
Arterial Thromboembolism in Cancer Patients Treated With Cisplatin: A Systematic Review and Meta-analysis
Proverbs-Singh T, Chiu S, Liu Z, Seng S, Sonpavde G, Choueiri T, Tsao C, Yu M, Hahn N, Oh W, Galsky M. Arterial Thromboembolism in Cancer Patients Treated With Cisplatin: A Systematic Review and Meta-analysis. Journal Of The National Cancer Institute 2012, 104: 1837-1840. PMID: 23093559, DOI: 10.1093/jnci/djs435.Peer-Reviewed Original ResearchConceptsArterial thromboembolic eventsIncreased risk of arterial thromboembolic eventsIncidence of arterial thromboembolic eventsNon-cisplatin-based chemotherapyPatients treated with cisplatin-based chemotherapyRisk of arterial thromboembolic eventsMeta-analysis of randomized controlled trialsCisplatin-based chemotherapyMeta-analysisConfidence intervalsRandom-effects modelCisplatin-basedRandomized Controlled TrialsIII trialsThromboembolic eventsRetrospective studySolid tumorsCase reportArterial thromboembolismCancer patientsIncreased riskControlled TrialsIncidence ratePatientsSystemic review
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply